Scinai Immunotherapeutics Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SCNI | AIM | SNGX | IMM.L | MDNA.TO | 6OP.F | |
|---|---|---|---|---|---|---|
| Market cap | 1.18M | 6.42M | 7.64M | 20.16M | 40.15M | 42.99M |
| P/E (TTM) | 0.0 | — | — | — | — | — |
| Forward P/E | — | -0.4 | -1.4 | 0.0 | -1.9 | — |
| Price/book | 0.0 | 0.6 | 1.1 | 10.7 | 24.2 | 1.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −95.93% | −90.78% | −73.91% | −67.26% | −72.88% | −67.91% |
| Today | −4.92% | +0.19% | −1.49% | −0.96% | +4.82% | −2.85% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All SCNI news ›Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing
Management estimates operating runway to late 2027, with potential extension into the third quarter of 2028 as later project phases under the recently announced CDMO agreement are activated and delivered JERUSALEM, Oct. 20, 2026…
Scinai Committed Customer Orders reach about $8.1M
Peraso Receives Production Order Exceeding $2.0 Million for 60 GHz Fixed Wireless Access Deployment Salesforce Signs Definitive Agreement to Acquire Braze Zorronet Secures Initial Commercial Order for Its Edge AI Systems from a Leading…
Scinai Immunotherapeutics Ltd. (SCNI) Raises $4.0M Via Private Placement, Warrant Deals
TradingView Scinai Immunotherapeutics Ltd. (SCNI) Raises $4.0M Via Private Placement, Warrant Deals Scinai closed a private placement of 2,458,334 ADSs with Series A-1 warrants and an immediate exercise of exist
Scinai Immunotherapeutics Announces $4.0 Million Financing Through a Private Placement and Warrant Inducement
Oct 14, 2026, 08:00 ET In addition, the Company entered into a warrant inducement agreement with the same investor for the immediate cash exercise of warrants issued in April 2026 to purchase an aggregate of 879,194 ADSs (the "Existing…
Scinai closes financing for about $4M gross
Scinai estimates runway to late 2027; activation of later CDMO phases and associated receipts could extend it into 2028. The private-placement ADSs and warrants, New Warrants and their underlying securities were unregistered. Scinai agreed…
Scinai Immunotherapeutics announces $4M financing deal; shares tumble
Scinai Immunotherapeutics (SCNI) raises ~$4M via private placement and warrant inducement; funds CDMO expansion and pipeline as shares drop. - Scinai Immunotherapeutics (SCNI) entered into securities purchase and warrant inducement…
Scinai Immunotherapeutics Regains Nasdaq Compliance, Draws Trader Focus
Scinai Immunotherapeutics Ltd. stocks have been trading up by 15.51 percent amid heightened optimism from its latest clinical developments Key Takeaways Regained compliance with Nasdaq’s $1.00 minimum bid price rule removes immediate…
PCNA Appoints New Customer Service Directors
News October 08, 2026 Becki Heinen joins the Counselor Top 40 supplier as director of customer success, while Brandy Ferguson was promoted from within to director of customer care. • PCNA (asi/66887) has hired Becki Heinen as director of…
[EFFECT] Scinai Immunotherapeutics Ltd. SEC Filing
Scinai Immunotherapeutics Ltd. SEC Filing (Oct 6, 2026) Stock Titan [EFFECT] Scinai Immunotherapeutics Ltd. SEC Filing Sentiment and the balance of points Rhea-AI Sentiment reads the wording of the document, how positive or negative its…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net6
- prnewswire.com4
- tradingview.com3
- seekingalpha.com2
- finviz.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 18 articles, not a forecast.